|
111
|
350
|
4fv8A |
Crystal structure of the erk2 complexed with e63 |
|
98
|
349
|
4fv5A |
Crystal structure of the erk2 complexed with ek9 |
|
108
|
347
|
4fv2A |
Crystal structure of the erk2 complexed with ek5 |
|
103
|
349
|
4fv4A |
Crystal structure of the erk2 complexed with ek7 |
|
105
|
348
|
4fuyA |
Crystal structure of the erk2 complexed with ek2 |
|
105
|
346
|
4fv1A |
Crystal structure of the erk2 complexed with ek4 |
|
103
|
350
|
4fv9A |
Crystal structure of the erk2 complexed with e71 |
|
121
|
346
|
3qyzA |
Crystal structure of erk2 in complex with an inhibitor |
|
111
|
350
|
4fmqA |
Crystal structure of human erk2 complexed with a mapk docking peptide |
|
114
|
355
|
3r63A |
Structure of erk2 (spe) mutant (s246e) |
|
114
|
346
|
3qywA |
Crystal structure of erk2 in complex with an inhibitor |
|
107
|
351
|
3qudA |
Human p38 map kinase in complex with 2-amino-phenylamino-benzophenone |
|
106
|
349
|
3queA |
Human p38 map kinase in complex with skepinone-l |
|
109
|
356
|
3pzeA |
Jnk1 in complex with inhibitor |
|
112
|
357
|
3py3A |
Crystal structure of phosphorylated p38alpha map kinase |
|
98
|
356
|
3ptgA |
Design and synthesis of a novel, orally efficacious tri-substituted thiophene based jnk inhibitor |
|
108
|
350
|
3pg3A |
Human p38 map kinase in complex with rl182 |
|
107
|
348
|
3p79A |
P38 inhibitor-bound |
|
103
|
348
|
3p78A |
P38 inhibitor-bound |
|
106
|
348
|
3p7bA |
P38 inhibitor-bound |
|
100
|
348
|
3p7cA |
P38 inhibitor-bound |
|
100
|
348
|
3p7aA |
P38 inhibitor-bound |
|
95
|
355
|
3oxiA |
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of jnk for the treatment of neurodegenerative diseases |
|
105
|
350
|
3p4kA |
The third conformation of p38a map kinase observed in phosphorylated p38a and in solution |
|
105
|
348
|
3p5kA |
P38 inhibitor-bound |
|
106
|
355
|
3oy1A |
Highly selective c-jun n-terminal kinase (jnk) 2 and 3 inhibitors with in vitro cns-like pharmacokinetic properties |
|
92
|
350
|
3odzX |
Crystal structure of p38alpha y323r active mutant |
|
109
|
346
|
3o71A |
Crystal structure of erk2/dcc peptide complex |
|
101
|
348
|
3oc1A |
Conformational plasticity of p38 map kinase dfg motif mutants in response to inhibitor binding |
|
110
|
347
|
3o8pA |
Conformational plasticity of p38 map kinase dfg motif mutants in response to inhibitor binding |
|
113
|
349
|
3nwwA |
P38 alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor |
|
102
|
348
|
3objA |
Conformational plasticity of p38 map kinase dfg mutants in response to inhibitor binding |
|
99
|
348
|
3o8uA |
Conformational plasticity of p38 map kinase dfg motif mutants in response to inhibitor binding |
|
99
|
349
|
3ocgA |
P38 alpha kinase complexed with a 5-amino-pyrazole based inhibitor |
|
92
|
350
|
3odyX |
Crystal structure of p38alpha y323q active mutant |
|
94
|
348
|
3obgA |
Conformational plasticity of p38 map kinase dfg mutants in response to inhibitor binding |
|
111
|
358
|
3o2mA |
Crystal structure of jnk1-alpha1 isoform complex with a biaryl tetrazol (a-82118) |
|
110
|
348
|
3oefX |
Crystal structure of y323f inactive mutant of p38alpha map kinase |
|
96
|
349
|
3od6X |
Crystal structure of p38alpha y323t active mutant |
|
102
|
348
|
3o8tA |
Conformational plasticity of p38 map kinase dfg-motif mutants in response to inhibitor binding |
|
102
|
357
|
3o17A |
Crystal structure of jnk1-alpha1 isoform |
|
106
|
348
|
3nnxA |
Crystal structure of phosphorylated p38 alpha in complex with dp802 |
|
111
|
348
|
3nnvA |
Crystal structure of p38 alpha in complex with dp437 |
|
103
|
348
|
3newA |
P38-alpha complexed with compound 10 |
|
118
|
357
|
3npcA |
Crystal structure of jnk2 complexed with birb796 |
|
112
|
348
|
3nnuA |
Crystal structure of p38 alpha in complex with dp1376 |
|
113
|
349
|
3nnwA |
Crystal structure of p38 alpha in complex with dp802 |
|
107
|
349
|
3mw1A |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
114
|
349
|
3mptA |
Crystal structure of p38 kinase in complex with a pyrrole-2-carboxamide inhibitor |
|
103
|
349
|
3mvmA |
P38 alpha map kinase complexed with pyrrolotriazine inhibitor 7v |